Page last updated: 2024-10-31

mitoxantrone and Immunoblastic Large-Cell Lymphoma

mitoxantrone has been researched along with Immunoblastic Large-Cell Lymphoma in 2 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cabanillas, F1
Rodriguez-Diaz Pavón, J1
Hagemeister, FB1
McLaughlin, P1
Rodriguez, MA2
Romaguera, JE1
Dong, K1
Moon, T1
Wilder, RB1
Tucker, SL1
Ha, CS1
Hess, MA1
Cabanillas, FF1
Cox, JD1

Trials

2 trials available for mitoxantrone and Immunoblastic Large-Cell Lymphoma

ArticleYear
Alternating triple therapy for the treatment of intermediate grade and immunoblastic lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine;

1998
Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas.
    International journal of radiation oncology, biology, physics, 2001, Jul-01, Volume: 50, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modalit

2001